资源描述：
《保心安胶囊联合美托洛尔片治疗室性早搏临床观察》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。
1、保心安胶囊联合美托洛尔片治疗室性早搏临床观察(河北邯郸明仁医院河北邯郸056006)【摘要】目的：研究保心安胶囊联合美托洛尔治疗室性早搏临床疗效。方法：采用随机数字表法，将200例室性早搏患者随机分为两组，治疗组100例在休息、吸氧、祛除病因基础上使用保心安胶囊和美托洛尔片联合治疗；对照组100例，给予在休息、吸氧、祛除病因基础上单纯使用美托洛尔片治疗，两组不同方案同时治疗4周，观察患者疗效及不良反应情况。结果：两组患者显效率无明显差异，但治疗组症状疗效总有效率为89%、动态心电图好转率88%,对照组症状疗效总有效率为48%、动态心电图好转率60
2、%,两组差异有统计学意义(P<0.05)而且治疗组治愈率明显高于对照组，两组差异有统计学意义(P<0.05),治疗组疗效优于对照组。结论：保心安胶囊联合美托洛尔片治疗室性早搏疗效肯定。【关键词】保心安胶囊：室性早搏；心律失常【中图分类号】R453【文献标识码】A【文章编号】1007-8231(2016)22-0010-03ClinicalobservationofcapsulecombinedwithmetoprololtabletsPosumonprematuretherapeuticroomYangXianghong,SongYu
3、qin,LiYuming,ZhangLihua,ZhangTiantao,HouBaosong,LiuXia.HandanMingrenHospital,Hebei,Handan,Hebei,056006【Abstract】ObjectiveTostudytheclinicaleffectofcapsulecombinedwithmetoprololinthetherapeuticroomprematurepeoplepeaceofmind.MethodsAccordingtotherandomnumbertablemethod,200patie
4、ntswithventricularprematurebeatwererandomlydividedinto2groups,100casesinthetreatmentgroupduringrest,oxygeninhalation,etiologicalfactorsbasedontheuseofcapsuleandmetoprololtabletscombinedwithPosumontreatment;100casesincontrolgroupweregivenintherest,oxygeninhalation,getridofthed
5、iseaseonthebasisof'simpleuseofmetoprololtreatmentatthesametime,twodifferentschemesfor4weeks.Theclinicalefficacyandadversereactionswereobserved.ResultsTheeffectiverateoftwogroupsofpatientshadnoobviousdifference,butthesymptomsinthetreatmentgroupthetotaleffectiveratewas89%,elect
6、rocardiogramimprovementratewas88%,controlgrouptotaleffectiverateofsymptomswas48%,electrocardiogramimprovementratewas60%,therewassignificantdifferencebetweentwogroups(P<0.05)andthetreatmentgroupcureratewassignificantlyhigherthanthecontrolgroup.Therewassignificantdifferenceb
7、etweentwogroups(P<0.05),thetreatmentgroupthanthecontrolgroup.ConclusionThecapsulecombinedwithmetoprololtabletsPosumonprematureclinicaltherapeuticroom.【Keywords]Posumoncapsule;Ventriculararrhythmia心律失常临床上十分常见iL可引起严重后果，发生于器质性心脏病的心律失常严重影响生活质量，甚则引起猝死。0前在治疗心律失常的用药上我们出现了“双难”窘境：治
8、疗室性早搏用药疗效欠佳，阵发性房颤缺乏长期冇效药物，对于缓慢性心律失常只能以肾上腺素、？受体兴奋剂、抗胆碱能药物等对症处理为主，但这些药
